Scarnose International Ltd reported a sharp rise in half-year revenue to Rs 16.17 crore for the period ending September 30, 2026. Despite doubling its top-line, the company’s net profit declined to Rs 0.04 crore, down from Rs 0.08 crore a year ago. Investors are now watching whether the company can improve margins amid rising costs and inventory fluctuations.
Scarnose International Reports Revenue Surge Amid Profit Compression
Revenue rose to Rs 16.17 crore from Rs 8.15 crore; Net profit fell to Rs 0.04 crore from Rs 0.08 crore.
Reader Takeaway: Strong topline growth is currently overshadowed by thinning bottom-line margins and rising operational expenses.
What just happened
Scarnose International Ltd released its unaudited standalone financial results for the half-year ending September 30, 2026. The board of directors approved the findings during their meeting on November 2, 2026. While the company saw its revenue from operations nearly double year-on-year, the profit after tax (PAT) saw a contraction, dropping to Rs 0.04 crore.
Why this matters
The jump in revenue signals significant scaling in business activity, with total income rising from Rs 8.15 crore to Rs 16.20 crore over the same period last year. However, the drop in net profit to Rs 0.04 crore suggests that increased operational costs are putting pressure on earnings. Basic and diluted earnings per share (EPS) have consequently decreased from 0.26 to 0.07.
Cost and Expense Analysis
Total expenses for the period reached Rs 16.16 crore. The company reported 'Cost of Materials Consumed' at Rs 25.72 crore, which was partially balanced by a positive inventory adjustment of Rs (9.65) crore. These figures highlight the volatility in trading-related expenses that the company is currently navigating.
Governance and Audit
The company’s statutory auditor, KM Chauhan & Associates, performed a limited review of the results. They issued an unmodified opinion, confirming that the financial statements comply with the required accounting standards and do not contain material misstatements.
What to track next
Investors should focus on how the management intends to optimize its cost structure. The ability to translate substantial revenue gains into consistent profit growth will be the primary indicator of operational health in the coming quarters.
